Novartis Increases Offer Price For Novartis India

Anonymous User | Login

Published: 28-May-2009

Novartis has increased the offer price for Novartis India to INR450 per share. The revised offer embodies a premium of 63% to the closing share price of INR275.6 of Novartis India on March 24, which was the last trading day before announcement of the offer.

This proposal represents Novartis' only and final price revision to this offer, as May 28 is the last day on which the price can be revised.

Earlier, Novartis had announced a tender offer to acquire an additional stake of up to approximately 39% in Novartis India, from public shareholders at a price of INR351 per share, on March 24, 2009.

Novartis has already deposited an escrow account with Bank of America, an amount of INR4.40 crore in cash as per the market regulator Sebi's regulation.

US HHS Purchases GSK’s Swine Flu Vaccine And Adjuvant System

GlaxoSmithKline (GSK) has got initial orders from the US Department of Health and Human Services (HHS) for A (H1N1) influenza vaccine antigen and the company’s proprietar ...

US To Grant $800m To Pharma Majors For Swine Flu Vaccine

The US government has announced plans to invest around $1 billion to support pharmaceutical companies for the development of swine flu vaccine. The US department of Healt ...

Elixir Signs Option Agreement with Novartis

US-based Elixir Pharmaceuticals, has entered into an agreement with Novartis, wherein Novartis has been granted an exclusive option to acquire the former, following the s ...

Glaxo to make Swine-Flu Vaccine

GlaxoSmithKline (Glaxo) is planning to produce a vaccine against the current strain of the A/H1N1 virus, responsible for the outbreak of swine-flu worldwide. Glaxo is try ...

Glaxo Provides 50m Pandemic Vaccines

In order to support governments and health authorities around the world to respond to the outbreak of global flu, British pharmaceutical giant GlaxoSmithKline has offered ...

Johnson & Johnson Acquires Cougar For $1b

Johnson & Johnson (J&J) has acquired Los Angeles-based biopharmaceutical company, Cougar Biotechnology for approximately $1 billion in a cash tender offer. Cougar will wo ...

KineMed Enters Into Collaboration With Bristol-Myers Squibb

KineMed, a translational and personalized medicine development company, has entered into a two year collaboration agreement with Bristol-Myers Squibb in the area of Alzhe ...

Cancer Research UK, GSK To Jointly Develop Anti-cancer Drug

Cancer Research UK and Cancer Research Technology (CRT) will commence the phase I clinical trial of GlaxoSmithKline's (GSK) anti-cancer drug 1070916A, an aurora kinase in ...

Phase I Trial On Compound Developed From AMRI, Bristol-Myers Squibb Collaboration

AMRI has announced that Bristol-Myers Squibb has submitted a Clinical Trial Application (CTA) to the Medical Products Agency (MPA) in Sweden for approval to initiate Phas ...

Xyntha' Sales Exceed BDI Pharma’s Q1 Projections

BDI Pharma, a wholesaler of biopharmaceutical products, has posted strong growth in sales of Wyeth’s XYNTHA Antihemophilic Factor (Recombinant) for the first quarter of 2 ...

Network Sites

Contract Research Clinical Trials Contract Services Drug Delivery Drug Discovery & Development OTC Regulatory Affairs Process and Production IT and Software Laboratory Instrumentation Manufacturing Fine & Specialty Chemicals Medical Devices Business Review Inward Investment Packaging

Mail sent successfully

Tell your friend about this article

Please enter a valid email address

Please enter your name

Please enter the mail body

Your Name: *

Your Email: *

Friend's Email: *

Email Body: *: I thought you would be interested in this article : http://otc.pharmaceutical-business-review.com/news/novartis_increases_offer_price_for_novartis_india_090528/

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

Parenteral Drug Association (PDA)

Pharmaceutical Information and Education Services ...

Nycomed

Contract Services ...

MHRA

The Medicines and Healthcare Products Regulatory Agency ...

Medilingua Translations

The Medical Translation Specialists ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Related Companies

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Merck KGaA

Merck KGaA (Merck) is a Germany-based company engaged in the manufacturing and distribu ...

Wyeth

Wyeth is engaged in developing and providing pharmaceuticals and healthcare products fo ...

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manuf ...

Johnson & Johnson

Johnson & Johnson (J&J) is engaged in the manufacture and sales of broad range of healt ...

Suppliers Product News

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Quality Control in Medical Translation

Various methods are available to ensure the quality of medical translations – but some are more effective than others.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750